Hematology Practice Questions

Q: A patient has normal prothrombin time (PT) and platelet count with increased activated partial thromboplastin time (aPTT), factor 8 levels given as 60 IU/ml, and no history of bleeding. What is the diagnosis?

Factor IX deficiency. The clinical presentation of a **normal PT**, **normal platelet count**, and **isolated prolonged aPTT** indicates a defect in the **intrinsic pathway** of the coagulation cascade (Factors XII, XI, IX, or VIII) [1]. 1. **Why Factor IX Deficiency is correct:** Factor IX is a key component of the intrinsic pathway. Its deficiency (Hemophilia B) leads to a prolonged aPTT while PT and bleeding time remain normal [2]. The question specifies **Factor VIII levels are normal (60 IU/ml)**, which effectively rules out Hemophilia A or von Willebrand Disease [3], making Factor IX deficiency the most logical diagnosis among the options. *Note: While severe Hemophilia B usually presents with bleeding, mild cases may be asymptomatic until surgical challenge.* 2. **Why other options are incorrect:** * **Thalassemia:** This is a quantitative hemoglobinopathy leading to microcytic hypochromic anemia; it does not affect the coagulation cascade or aPTT. * **Factor VIII Inhibitors:** These are acquired antibodies against Factor VIII. While they prolong aPTT, the **Factor VIII levels would be significantly low**, not normal (60 IU/ml). * **Lupus Anticoagulant (LA):** While LA prolongs aPTT in vitro and typically presents without bleeding, it is an antiphospholipid antibody associated with **thrombosis**, not a factor deficiency. Given the specific mention of Factor VIII levels, the question directs focus toward the intrinsic factor hierarchy. **High-Yield Clinical Pearls for NEET-PG:** * **Isolated prolonged aPTT:** Think Factors VIII, IX, XI, XII, or Lupus Anticoagulant [1]. * **Isolated prolonged PT:** Think Factor VII deficiency (Extrinsic pathway) [1]. * **Mixing Study:** If aPTT corrects with normal plasma, it’s a **factor deficiency**; if it does not correct, it’s a **factor inhibitor** (like Lupus Anticoagulant) [1]. * **Factor XII Deficiency:** Characterized by a very high aPTT but **no clinical bleeding** tendency.

Q: What is the best prognostic indicator of multiple myeloma at the time of diagnosis?

Beta 2 microglobulin. The prognosis of Multiple Myeloma (MM) is currently determined by the **International Staging System (ISS)**, which identifies **Serum Beta-2 Microglobulin (β2M)** as the single most important prognostic marker [1]. 1. **Why Beta-2 Microglobulin is correct:** β2M is a component of the MHC Class I molecule found on the surface of nucleated cells. In MM, its levels reflect the **total tumor burden** and the **severity of renal impairment**. Higher levels correlate with a larger mass of plasma cells and poorer survival outcomes [1]. It is the cornerstone of both the ISS and the Revised-ISS (R-ISS) staging systems. [1] 2. **Why other options are incorrect:** * **Number of myeloma cells (A):** While the percentage of plasma cells in the bone marrow is used for *diagnosis* (e.g., >10% for MM), it does not correlate as accurately with survival or prognosis as biochemical markers like β2M. [1] * **Alkaline Phosphatase (C):** In MM, bone lesions are purely **osteolytic** (mediated by osteoclasts). Because there is no osteoblastic activity, the ALP level is typically **normal**. An elevated ALP in a suspected MM patient should prompt a search for an alternative diagnosis or a fracture. * **Hypercalcemia (D):** While hypercalcemia is a "CRAB" feature indicating end-organ damage, it is a reversible complication and not as reliable a predictor of long-term survival as β2M. **High-Yield Clinical Pearls for NEET-PG:** * **ISS Staging:** Stage I (β2M <3.5 mg/L + Albumin ≥3.5 g/dL); Stage III (β2M ≥5.5 mg/L). [1] * **R-ISS:** Adds **LDH levels** and **High-risk Cytogenetics** [t(4;14), t(14;16), or del(17p)] to the standard ISS for even more precise prognosis. * **Serum Albumin:** Low albumin is also a poor prognostic sign in MM (reflecting IL-6 mediated suppression). [1]

Q: Autoimmune destruction of platelets is seen in which of the following conditions?

Systemic Lupus Erythematosus (SLE). **Explanation:** The correct answer is **Systemic Lupus Erythematosus (SLE)**. **1. Why SLE is correct:** SLE is a multisystem autoimmune disorder characterized by the production of various autoantibodies [1]. Hematological involvement is a hallmark of the disease. Thrombocytopenia in SLE occurs primarily due to **immune-mediated destruction of platelets**, where anti-platelet antibodies (IgG) coat the platelets, leading to their premature clearance by the splenic macrophages [2]. This mechanism is identical to **Immune Thrombocytopenic Purpura (ITP)**. In fact, ITP can often be the presenting feature of SLE. **2. Why other options are incorrect:** * **Polyarteritis Nodosa (PAN):** This is a necrotizing vasculitis of medium-sized arteries. While it causes multisystem involvement (renal, GI, skin), it does not typically involve autoantibody-mediated destruction of platelets. * **Rheumatoid Arthritis (RA):** While RA is autoimmune, its primary hematological association is **Felty’s Syndrome** (RA, Splenomegaly, and Neutropenia). Thrombocytopenia is not a classic feature unless secondary to drug toxicity (e.g., methotrexate) or hypersplenism. * **Sarcoidosis:** This is a granulomatous disease. Hematological issues usually involve lymphopenia or anemia of chronic disease. Thrombocytopenia, if present, is usually due to splenic sequestration (splenomegaly) rather than direct autoimmune destruction. **Clinical Pearls for NEET-PG:** * **Evans Syndrome:** The coexistence of Autoimmune Hemolytic Anemia (AIHA) and Immune Thrombocytopenia (ITP); frequently associated with SLE. * **Most common hematological abnormality in SLE:** Anemia of Chronic Disease (however, Lymphopenia is the most *specific* hematologic criteria in the ACR classification) [2]. * **Mechanism:** Type II Hypersensitivity reaction (Antibody-mediated) [3].

Q: All of the following can lead to the development of overt anemia in patients with long-standing compensated hemolytic anemia, EXCEPT:

Hypothyroidism. In patients with **compensated hemolytic anemia**, the bone marrow increases erythropoiesis (up to 6–8 times the normal rate) to match the shortened lifespan of red blood cells. **Overt anemia** occurs when this delicate balance is disrupted, either by an increased demand for RBCs or a decrease in marrow production. ### Why Hypothyroidism is the Correct Answer **Hypothyroidism** typically causes a mild, normocytic, hypoproliferative anemia due to a generalized decrease in metabolic rate and tissue oxygen demand, which leads to reduced erythropoietin (EPO) production. However, it does **not** cause an acute "decompensation" or a sudden crisis in hemolytic states. Unlike the other options, it does not acutely interfere with the high-turnover requirements of a hemolytic marrow. ### Explanation of Incorrect Options * **Pregnancy:** Increases plasma volume (dilutional effect) and significantly raises the demand for RBC production and nutrients. This can tip a compensated state into overt anemia. * **Renal Failure:** Leads to a deficiency in **Erythropoietin (EPO)**. In hemolysis, the marrow requires high levels of EPO to maintain compensation; loss of EPO leads to a rapid drop in hemoglobin. * **Folate Deficiency:** Hemolysis creates a high-turnover state with a massive demand for folate for DNA synthesis. If stores are depleted, a **megaloblastic/aplastic crisis** occurs, causing profound anemia. ### High-Yield Clinical Pearls for NEET-PG * **Aplastic Crisis:** Most commonly caused by **Parvovirus B19**, which infects erythrocyte precursors. * **Megaloblastic Crisis:** Caused by folate deficiency due to chronic hyperactive erythropoiesis. * **Hemolytic Crisis:** An acute acceleration of hemolysis (e.g., G6PD deficiency after oxidant stress). * **Splenic Sequestration:** Common in Sickle Cell Anemia; causes sudden pooling of blood in the spleen and acute anemia.

Q: Which of the following is NOT included in the differential diagnosis of microangiopathic hemolytic anemia?

Myocardial infarction. **Explanation:** Microangiopathic Hemolytic Anemia (MAHA) is a descriptive term for non-immune hemolytic anemias characterized by **fragmentation of red blood cells (schistocytes)** [1]. This occurs due to mechanical shearing of erythrocytes as they pass through small blood vessels obstructed by fibrin or platelet thrombi [1]. **Why Myocardial Infarction (MI) is the correct answer:** MI is a macrovascular event typically caused by the occlusion of a coronary artery by an atherosclerotic plaque or thrombus. It does not involve systemic microvascular pathology or the mechanical shearing of RBCs. Therefore, it is not a cause of MAHA. **Analysis of Incorrect Options:** * **Sepsis:** Severe sepsis can trigger **Disseminated Intravascular Coagulation (DIC)** [2]. In DIC, widespread fibrin deposition in the microvasculature leads to RBC fragmentation and schistocyte formation [1]. * **Hemolytic Uremic Syndrome (HUS):** This is a classic cause of MAHA, characterized by the triad of microangiopathic anemia, thrombocytopenia, and acute renal failure, typically due to Shiga toxin-induced endothelial damage [1]. * **Eclampsia:** Preeclampsia and eclampsia can lead to **HELLP syndrome** (Hemolysis, Elevated Liver enzymes, Low Platelets), which is a specific form of MAHA occurring in pregnancy [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Hallmark Finding:** The presence of **schistocytes** (helmet cells) on a peripheral blood smear (>1% is significant). * **Laboratory Markers:** Elevated LDH, decreased haptoglobin, and indirect hyperbilirubinemia (all markers of hemolysis), with a **negative Direct Coombs Test** (confirming non-immune etiology). * **Primary Differential (The "Pentad" of TTP):** Fever, Anemia (MAHA), Thrombocytopenia, Neurological symptoms, and Renal failure. * **Other Causes:** Malignant hypertension, Systemic Sclerosis (Scleroderma renal crisis), and prosthetic heart valves (Macroangiopathic) [1].

Q: A 33-year-old alcoholic patient on anti-tuberculosis treatment presents with increased serum iron and increased transferrin saturation. What is the most likely diagnosis?

Sideroblastic anemia. ### Explanation **Correct Answer: B. Sideroblastic Anemia** The clinical presentation points toward **Sideroblastic Anemia**, a defect in heme synthesis. In this condition, iron is available but cannot be incorporated into protoporphyrin to form heme. This leads to iron overload in the mitochondria of erythroid precursors, forming "ringed sideroblasts." * **Underlying Mechanism:** The patient has two major risk factors: **Alcoholism** (a common cause of acquired sideroblastic anemia) and **Anti-Tuberculosis Treatment (Isoniazid)**. Isoniazid is a Vitamin B6 (Pyridoxine) antagonist. Since B6 is a mandatory cofactor for **ALA synthase** (the rate-limiting enzyme in heme synthesis), its deficiency leads to impaired heme production and subsequent iron accumulation. * **Iron Profile:** Because iron is not being utilized, serum iron increases, and transferrin saturation rises, reflecting systemic iron overload. **Why other options are incorrect:** * **A. Iron Deficiency Anemia:** Characterized by *decreased* serum iron and *decreased* transferrin saturation (opposite of this case). * **C. Megaloblastic Anemia:** While common in alcoholics (Folate deficiency), it typically presents with normal or slightly elevated iron; however, it does not explain the specific association with INH or the classic iron-overload profile seen here. * **D. Anemia of Chronic Disease:** Characterized by *decreased* serum iron and *decreased* TIBC due to iron sequestration in macrophages (hepcidin-mediated). **NEET-PG High-Yield Pearls:** * **Gold Standard Diagnosis:** Bone marrow examination showing **Ringed Sideroblasts** (Prussian Blue stain). * **Management:** Discontinue the offending agent (Alcohol/INH) and supplement with **Pyridoxine (Vitamin B6)**. * **Lead Poisoning:** Another cause of sideroblastic anemia; look for "basophilic stippling" and "Burtonian lines" on gums.

Question 1

A patient has normal prothrombin time (PT) and platelet count with increased activated partial thromboplastin time (aPTT), factor 8 levels given as 60 IU/ml, and no history of bleeding. What is the diagnosis?

Accepted Answer

Factor IX deficiency

Answer

Thalassemia

Answer

Factor VIII inhibitors

Answer

Lupus anticoagulant

Question 2

What is the best prognostic indicator of multiple myeloma at the time of diagnosis?

Accepted Answer

Beta 2 microglobulin

Answer

Number of myeloma cells in the marrow

Answer

Alkaline phosphatase level

Answer

Hypercalcemia

Question 3

A 27-year-old female presents with easy fatigue and light-headedness. She also has a dry cough and fever for the past few days. On examination, she is pale, her lungs are clear, and the rest is normal. A chest x-ray shows patchy bilateral infiltrates; the hemoglobin is 8.4 g/dL, reticulocyte count of 6%, and many spherocytes on the peripheral blood film. Which of the following is the most likely significance of the spherocytosis on the blood film?

Accepted Answer

Coombs'-positive hemolytic anemia

Answer

Multiple long bone fractures

Answer

Hereditary elliptocytosis

Answer

Glucose-6-phosphate dehydrogenase (G6PD) deficiency

Question 4

A 42-year-old male presents with fatigue, pale skin, and exertional dyspnea. Laboratory findings reveal macrocytic, hyperchromic anemia with hyper-segmented neutrophils. Folate levels are normal. The patient reports long-term omeprazole use for gastric reflux disease. Which of the following interventions is indicated for this patient?

Accepted Answer

Vitamin B12 injections

Answer

Oral folic acid supplementation

Answer

Vitamin B6 injections

Answer

Intrinsic factor injections

Question 5

Which of the following statements is NOT true about heparin-induced thrombocytopenia?

Accepted Answer

It is more common with unfractionated heparin than low molecular weight heparin.

Answer

Low molecular weight heparins should not be used for treatment.

Answer

It causes both arterial and venous thrombosis.

Answer

It typically occurs after about a week of heparin therapy.

Question 6

Autoimmune destruction of platelets is seen in which of the following conditions?

Accepted Answer

Systemic Lupus Erythematosus (SLE)

Answer

Polyarteritis Nodosa (PAN)

Answer

Rheumatoid Arthritis (RA)

Answer

Sarcoidosis

Question 7

All of the following can lead to the development of overt anemia in patients with long-standing compensated hemolytic anemia, EXCEPT:

Accepted Answer

Hypothyroidism

Answer

Pregnancy

Answer

Renal failure

Answer

Folate deficiency

Question 8

Which of the following is NOT included in the differential diagnosis of microangiopathic hemolytic anemia?

Accepted Answer

Myocardial infarction

Answer

Sepsis

Answer

Hemolytic uremic syndrome

Answer

Eclampsia

Question 9

A 33-year-old alcoholic patient on anti-tuberculosis treatment presents with increased serum iron and increased transferrin saturation. What is the most likely diagnosis?

Accepted Answer

Sideroblastic anemia

Answer

Iron deficiency anemia

Answer

Megaloblastic anemia

Answer

Anemia of chronic disease

Question 10

A 47-year-old woman presents with fever, headache, confusion, and jaundice for one week. She underwent a hysterectomy two months ago and recently started estrogen replacement therapy. On admission, her temperature is 38.7 C, blood pressure is 140/90 mm Hg, pulse is 98/min, and respiratory rate is 20/min. She is disoriented to time and place. Physical examination reveals jaundiced sclerae and skin, purpura on the trunk, and bleeding gums. Her platelet count is 25,000/mm3, hematocrit is 24%, and creatinine is 4.9 mg/dL. Lactate dehydrogenase (LDH) and indirect bilirubin are elevated. Coagulation tests are within normal limits, but the bleeding time is increased; fibrin-split products and Coombs test are negative. A peripheral blood smear shows schistocytes, helmet-shaped cells, and cells with a triangular shape. Which of the following is the most likely diagnosis?

Accepted Answer

Thrombotic thrombocytopenic purpura

Answer

Autoimmune hemolytic anemia

Answer

Disseminated intravascular coagulation

Answer

Hemolytic-uremic syndrome

Hematology — MCQs

Hematology — MCQs

On this page

Practice by Chapter

Want unlimited practice?